This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "20170119 PLA WGM"

From HL7Wiki
Jump to navigation Jump to search
Line 38: Line 38:
 
===============================================================================--->
 
===============================================================================--->
 
|-
 
|-
| || Calvin Beebe
+
| x|| Calvin Beebe
 
|-
 
|-
 
| ||Lorraine Constable
 
| ||Lorraine Constable
Line 44: Line 44:
 
| || Jean Duteau,
 
| || Jean Duteau,
 
|-
 
|-
| || Tony Julian  
+
|x || Tony Julian  
 
|-
 
|-
| || Paul Knapp
+
|x || Paul Knapp
 
|-
 
|-
| || Austin Kreisler,
+
|x|| Austin Kreisler,
 
|-
 
|-
| || Lynn Laakso
+
|x || Anne Wizauer
 
|-
 
|-
| || Mary Kay McDaniel
+
|x || Mary Kay McDaniel
 
|-
 
|-
 
| || Brian Pech
 
| || Brian Pech
Line 80: Line 80:
  
 
===Minutes===
 
===Minutes===
Convened
+
*Updates from the week:
 
+
**Austin gave an update to TSC on progress
Adjourned
+
**Discussion over future of V3 issues – vague discussion at TSC regarding potential V3 product family.
 +
**CDAMG: Proposed M&C will go to TSC in Madrid. CDAMG will hold first WGM meeting in September. Group is separate from Structured Docs.  Discussion over tension between clinical domains and technical committees. Mix of management bodies – need implementers representing stakeholders, provider perspective, payer perspective. Would be nice to have a nurturer and a project manager in the mix who could bring things together. Technical bodies often lack business knowledge. Currently we have SGB chair, CTO, four SD members, one international…
 +
**Austin: Need to focus on roles and fill that way. Discussion over type of representation that could potentially come from SDs. Need to remember it’s an international standard base. MK displays structure section in M&C. Roles: PM, Negotiator/nurturer, provider, payer, implementer, international, sampling of domain committees, sampling of the steering committees.
  
 
===Meeting Outcomes===
 
===Meeting Outcomes===
Line 103: Line 105:
 
|}
 
|}
  
© 2017 Health Level Seven® International.  All rights reserved
+
© 2017 Health Level Seven® International.  All rights reserv

Revision as of 16:40, 8 February 2017

return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program

HL7 PLA Call Minutes

Location: Blanco

Date: 2016-01-20
Time: 8:00 AM
Facilitator Mary Kay/ Austin Note taker(s) Anne
Attendee Name


x Calvin Beebe
Lorraine Constable
Jean Duteau,
x Tony Julian
x Paul Knapp
x Austin Kreisler,
x Anne Wizauer
x Mary Kay McDaniel
Brian Pech
John Roberts
Andy Stechishin
no quorum definition

Agenda

  • Agenda review
  • Updates from the week

Minutes

  • Updates from the week:
    • Austin gave an update to TSC on progress
    • Discussion over future of V3 issues – vague discussion at TSC regarding potential V3 product family.
    • CDAMG: Proposed M&C will go to TSC in Madrid. CDAMG will hold first WGM meeting in September. Group is separate from Structured Docs. Discussion over tension between clinical domains and technical committees. Mix of management bodies – need implementers representing stakeholders, provider perspective, payer perspective. Would be nice to have a nurturer and a project manager in the mix who could bring things together. Technical bodies often lack business knowledge. Currently we have SGB chair, CTO, four SD members, one international…
    • Austin: Need to focus on roles and fill that way. Discussion over type of representation that could potentially come from SDs. Need to remember it’s an international standard base. MK displays structure section in M&C. Roles: PM, Negotiator/nurturer, provider, payer, implementer, international, sampling of domain committees, sampling of the steering committees.

Meeting Outcomes

Actions


© 2017 Health Level Seven® International. All rights reserv